We strive for the happiness and better value for everyone
by constantly conducting research activities
Yurastar Injection
Therapeutic Group
Treatment for Osteoporosis
Active Ingredients
Zoledronic Acid Monohydrate 5.33mg/100mL (5mg as anhydride)
1. Treatment of osteoporosis (1) To reduce the incidence of fractures (hip, vertebral and non-vertebral osteoporosis-related fractures) (2) To reduces the incidence of new clinical fractures in patients at high risk of fracture, defined as a recent low-trauma hip fracture (3) to increase bone mass in men with osteoporosis 2. Treatment and prevention of postmenopausal osteoporosis 3. Treatment and prevention of glucocorticoid-induced osteoporosis 4. Treatment of Paget’s disease of bone
Once a year, as an intravenous infucion over no less than 15 minutes
Sealed container, room temperature(1~30℃)
1 bottle (100mL/bottle)